Understanding protein aggregation from the view of monomer dynamics

Area of Science:

• Biochemistry and Molecular Biology
• Biophysics
• Disease Pathogenesis

Background:

• Protein aggregation is implicated in numerous debilitating diseases.
• Understanding the initial steps of protein aggregation is crucial for disease intervention.
• Current research focuses on the complex dynamics governing protein aggregation.

Purpose of the Study:

• To review the earliest stages of protein aggregation.
• To propose a model where monomer reconfiguration dynamics control initial aggregation.
• To discuss the implications for developing small molecule aggregation inhibitors.

Main Methods:

• Literature review of experimental evidence supporting the proposed model.
• Analysis of the relationship between monomer reconfiguration dynamics and bimolecular diffusion.
• Discussion of therapeutic strategies targeting early aggregation steps.

Main Results:

• Early protein aggregation is governed by monomer reconfiguration dynamics.
• Aggregation rates are modulated by the interplay between reconfiguration speed and bimolecular diffusion.
• A critical balance between these factors leads to accelerated aggregation.

Conclusions:

• Monomer reconfiguration dynamics are a key determinant of protein aggregation initiation.
• Targeting the balance between reconfiguration and diffusion may offer novel therapeutic avenues.
• Small molecule inhibitors hold promise for preventing aggregation-based diseases by modulating these dynamics.